# Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

Study · id `cardio:ct-nct05130268` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05130268](<https://clinicaltrials.gov/study/NCT05130268>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05130268

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 339 participants.

## Technical summary

Registry record NCT05130268. Randomized; no masking; primary purpose treatment. Start 2021-10-29 (actual); primary completion 2024-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 339 participants (enrolled count; ClinicalTrials.gov record NCT05130268, source copy `cardio:ctgov-nct05130268-2025-01-28`, retrieved 2026-10-26)
- Started: 2021-10-29 (actual) (ClinicalTrials.gov record NCT05130268, source copy `cardio:ctgov-nct05130268-2025-01-28`, retrieved 2026-10-26)
- Primary completion: 2024-01-31 (actual) (ClinicalTrials.gov record NCT05130268, source copy `cardio:ctgov-nct05130268-2025-01-28`, retrieved 2026-10-26)
- Completion: 2024-06-30 (actual) (ClinicalTrials.gov record NCT05130268, source copy `cardio:ctgov-nct05130268-2025-01-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05130268, source copy `cardio:ctgov-nct05130268-2025-01-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05130268-2025-01-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
- Acronym: CHANGE-AFIB
- Condition: Atrial Fibrillation
- Intervention (Drug): Dronedarone
- Lead sponsor: American Heart Association
- Lead sponsor class: OTHER
- Collaborator: Duke Clinical Research Institute
- Collaborator class: OTHER
- Collaborator: Sanofi
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: American Heart Association (`core:aha`)
- Registry lists this organization as a collaborator: Duke Clinical Research Institute (`cardio:org-duke-clinical-research-institute`)
- Registry lists this organization as a collaborator: Sanofi (`cardio:org-sanofi`)

## Provenance

Content hash: 16cf8e5034568fddfbeb5da74a5bc3816530c28309dff14faa894c418f307f6c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
